Dr. Stephen Channey

Dr Channey.jpg

Stephen Channey is a leading Regenerative and  Preventive Medicine specialist. Dr. Channey is a graduate of the University of Richmond VA and St Georges University School of Medicine. He has a proven history of excellence in the medical field including:

  • 3 years private practice OB/GYN in Washington D.C.
  • 16 years OB/GYN Hospitalist at Memorial Regional Hospital Hollywood Florida
  • 10 years as Medical Director of Memorial Regional Hospitalist Group
  • 20 years experience providing hormone replacement therapy to Women and Men
  • More than 400 CME credits in study of natural and bioidentical hormone replacement therapy
  • Certified in Autologous Stem Cell Therapies
  • Certified by Worldlink Medical in BHRT

Dr. Channey is currently the Medical Director at Regenestem located at 9633 West Broward Blvd Suite 1 Plantation, FL 33324 and Medical Vitality Clinic located at 3860 Sheridan St. Suite B, Hollywood Florida 33021.

Dr. Ana Hernandez

Personal Statement

My research interests involve the fields of immunology, cellular and molecular biology. My research experience provided me with a vast knowledge in multiple areas including molecular biology, cellular Immunology, stem cell technology and flow cytometry. After I finished my Bachelor’s degree I started to work on the molecular pathways implicated in the development of leukemia and lymphoma diseases. During that period, I acquired a strong background in the mechanisms leading to B and T cell rearrangements and basic methodologies in molecular biology. I started my Ph.D at the Cancer Research in London, United Kingdom where I studied the role of alternative splicing patterns of BCR/ABL trancripts in the generation of the blast crisis of chronic myeloid leukemia. I finished these studies at the University of Dusseldorf, Germany. For my postoctoral training I worked on the culture of human mesenchymal stem cells derived from bone marrow or cord blood and their differenciation into cardiomyocytes. I continues my post doctoral training at the University of Miami where I had the opportunity to acquire a better understanding of the processes involved in generation of immune tolerance after transplantation. After I finished my post-doc, I focused my research on the immune monitoring of patients after transplant to understand the mechanisms of graft tolerance. I was also involved in the immunemonitoring of animal model to assess the effect of mesenchymal stem cells (MSC) on allogeneic transplant which included the expansion of MSC from Bone Marrow and Characterization of MSC by phenotypic analysis and functional assays. One of my major interest is in the field of regenerative medicine where stem cells have been successfully use in the treatment of multiples medical conditions.    

B. Positions  

·         09/84-04/92: Research Associate. Institute of Hematology and Immunology, Molecular Biology Department, Havana, Cuba.

·         05/92-05/93: Scientist. Institute of Neuropathology, Heinrich-Heine University, Dusseldorf, Germany.  

·         06/93-05/99: Scientist. Institute of Transplantation and Cell Therapies, Heinrich-Heine University, Dusseldorf, Germany.

·         07/01-02/03: Scientist. Kourion Therapeutics AG, Dusseldorf, Germany.

·         03/03-12/06: Post-Doc. Department of Surgery, Division of Transplantation, University of Miami, USA.

·         01/07-05/16: Associate Scientist. Diabetes Research Institute, University of Miami, USA

·         06/16-Present: Miami Research Associates (MRA), Miami, Fl (private company)


03/89-10/89: Grant supported by the Word Health Organization (WHO) to work in the molecular pathways involved in the chronic myeloid leukemia and acute lymphocytic leukemia at the Institute of Cancer Research in London, United Kingdom.  


·         Contribution to Science

The list of peer reviewed publications listed below is a reflection of my contribution to these fields of science.  

Selected Publications (in descendent chronological order)

·         Kenyon NS, Willman MA, Han D, Hernandez A, Rabassa A, Diaz A, Geary JC, Kenyon NM, Bartholomew

A, McHenry K, Salomon D and Berman DM. Mesenchymal Stem Cells Enhance Rejection Free and Overall Islet Allograft Survival (This work has been accepted for oral presentation at the 2015 American Transplant Congress (ATC) at the Pennsylvania Convention Center, May 2-6, 2015).

·         Hernandez A, Han D, Oberholzer J, Ricordi C, Alejandro R, Kenyon NS. Effect of lysofylline on the immune response in islet transplant patients (abstract). J Clinical Immunology. 33 (3), 692, 2013. (This work has been accepted as a poster presented in Clinical Immunology Society Annual Meeting, April 25-28, 2013, Miami, FL, poster #1).

·         Hernandez A, Burger M, Blomberg BB, Ross WA, Gaynor JJ, Lindner I, Cirocco R, Mathew JM, Carreno M, Jin Y, Lee KP, Esquenazi V, Miller J.: Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches. Hum Immunol. 68, 715, 2007.

·         Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P. :Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002 Oct 8;106 (15):1913-8.

·         Strauer,B.E; Brehm, M; Zeus, T; Gattermann, N; Hernandez, A; Sorg, R.V; Kögler, G; Wernet, P.: Myocardial regeneration after intracoronary transplantation of human autologous stem cells following acute myocardial infarction. Deutsche Medicinische Wochenschr. 126: 932-938, 2001  

·         Hernández, A.; Meyer, A.; Enczmann, J.; Ackermann, R.; Wernet, P.: Establishment of experimental conditions for the rapid detection of mutations in the VHL gene by parallel temeprature gradient gel electrophoresis. Electrophoresis 20, 1958,1999.

·         Hernández, A.; Zöller, K.; Enczmann, J.; Ebert, T.; Schmitz-Draeger, B.; Ackermann, R.; Wernet, P.: Differential transfection efficiency rates of the GM-CSF gene into human renal carcinoma cell lines by lipofection. Cancer Gene Therapy 4, 59, 1997 .

·         Wenzel, M., Enczmann, J., Uhrberg, M, Hernandez, A., Wiese, U., Ackermann, R., Ebert, T.; SchmitzDraeger, Wernet, P.: Screening for renal carcinoma associated mutations in the von Hippel- Lindau tumor suppressor gene by temperature gradient gel electrophoresis. Electrophoresis 18: 45, 1997.

·         Kögler, G.; Hernández, A.; Heyll, A.; Wolf H.H.; Wernet, P.: Qualitative assessment of mixed chimerism after bone marrow transplantation with regard to leukemic relapse. Cancer Detection and Prevention 20: 601, 1996 .

·         Hernández, A.; Uhrberg, M.; Enczmann, J.; Witt, I.; Reitsma, P.H.; Wernet, P.: Rapid identification of gene defects in protein C deficiency by temperature gradient gel electrophoresis. Blood Coagulation and Fibrinolysis 6, 23, 1995.

·         Hernández, A.; Magario,C; Gispert,S.; Santos,N.; Lunkes,A.; Orozco, G.; Heredero,L.; Beckmann,J.; Auburger, G.: Genetic mapping of the spinocerebellar ataxia 2 (SCA 2) locus on chromosome 12q23-q24.1. Genomic 25, 433, 1995

·         Hernández,A.; Hernández,P.; Corral,L.; Muñiz,A.; Aláez,C.; Espinosa,E.; Fernández,O.; Martínez,G.: p53 gene rearrangements in chronic myelocytic leukemia. Ann. Hematol 66:81, 1993.

·         Silveira, I.; Manaia, A.; Melki, J.; Magarino, C.; Lunkes, A.; Hernandez, A.; Gispert, S.; Burlet, P.; Rozet, J.M.; Coutinho, P.; Auburger, G.: Machado-Joseph disease is genetically different from Holguin dominant ataxia (SCA2). Genomics 17: 556, 1993.

·         Gispert,S.; Twells,R.; Orozco,G.; Brice, A.; Weber,J.; Heredero,L.; Scheufler,K.; Riley,B.; Allotey,R.; Northers,C.; Hillermann,R.; Lunkes,A.; Khati,C.; Stevanin,G.; Hernández,A.; Magarino,C.; Klockgether,T.; Durr,A.; Chneiweiss,H.; Enczmann,J.; Farral,M.; Beckmann,J.; Mullan,M.; Wernet,P.; Agid,Y.; Freund,H-J.; Williamson, R.; Auburger,G.; Chamberlain,S.: Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1.Nature Genetics 4:295, 1993.

·         Hernández,A.; Corral,L.; Muñiz,A.; Aláez,C.; Dorticós, E.; Martínez,G.; Hernández,P.: Lack of M-bcr rearrangement with b3a2 juntion revealed by polymerase chain reaction in a case of Philadelphia-positive intermediate lymphocytic lymphoma in leukemic phase. Brit.J.Haematol 82:626, 1992.

·         Hernández,A.; Corral,L.; Muñiz,A.; Aláez,C.; Espinosa,E.; Martínez,G.; Hernández,P.: Further evidence for the molecular heterogeneity of chronic myeloid leukaemia. Ann Hematol 62; 217, 1991

·         Hernández,A.; Corral,L.; Muñiz,A.; Aláez,C.; Martínez G.: LMC atípica con polimorfismo del gen BCR. Sangre, 36: 497, 1991.

·         Hernández,A.; Osterholz,J.; Price,C.M.; Wiedemann,L.M.; Gordon M.Y.; Goldman,J.M.; Morgan,G.J.: Detection of hybrid BCR/ABl messenger RNA in single CFU-GM colonies using the polymerase chain reaction. Experimental Hematology. 18:1142, 1990.

·         Morgan,G.; Hernández,A.; Chan,L.C.; Huges,T.; Martiat,T.; Wiedemann,L.M.: The role of alternative splicing patterns of BCR/ABL trancripts in the generation of the blast crisis of chronic myeloid leukaemia. British.J.Hematology 76:33, 1990.

Book chapter

·         Hernández, A.; Uhrberg, M.; Enczmann, J.; Witt, I.; Reitsma, R.; Wernet, P.: Rapid detection of point mutations in the protein C gene by temperature gradient gel electrophoresis. 25 Hämophilie-Symposion, Hamburg 1994, pg 147, editors Springer-Velag, Berlin, Heidelberg, New York, London, Paris, Tokyo, Hon Kong, Barcelona, Budapest.

Dr Goel family physician practicing in “downtown” Brampton for over the past 10 years. Born in Montreal, he grew up in Mississauga and obtained his medical degree from University of Toronto in 1995. He completed his family medicine residency in 1997 from St Mary’s Hospital in Montreal before coming to “set up shop” in Brampton. Currently, Dr. Goel is the Lead Physician for the Wise Elephant Family Health Team in Brampton. 


Dr Mahl maintains an active practice in Regenerative Medicine/Preventive Aging and Pain Management in Coral Gables, Florida with an emphasis on stem cell regenerative therapies and anti-aging.

He lectures nationally and internationally on topics ranging from Regenerative Medicine to Preventive Aging encompassing Prolotherapy, Platelet Rich Plasma injections and Bone Marrow/Adipose derived Stem Cells.

He views stem cells as the new frontier of medicine today, with unlimited possibilities to help people and eliminate many forms of sickness and suffering and sees stem cell and regeneration as the most important research in medicine today

With his knowledge and proficiency in these techniques, he participates in International missions teaching other doctors’ how to do these procedures and treating patients who could benefit from the treatments. He teaches and trains doctors in the art and science of Regenerative Medicine in his Coral Gables office and teaches and trains physicians for Regenestem in Latin America.

Dr. Salerno served as a clinical preceptor at the Yale University School of Medicine (3 years), as Medical Director of St. Vincent’s Immediate Health Care in Shelton, Connecticut


One of the doctors at the forefront of stem cell therapy in the Philippines is Cosmetic Surgeon Dr. Eric Yalung. Certified by the Philippine Board of Cosmetic Surgery, Dr. Yalung is a fellow of the Philippine Society for Cosmetic Surgery and Asian Pacific Academy of Cosmetic Surgery, consultant and trainer of Regenestem in Miami, and has undergone special 

Reid Eckert has been a Certified Nutritional Counselor, educated from prestigious Bastyr College, for the past 25 years. His store, Nutrition Direct is located in the Fort Lauderdale, FLa area, although his clients live across and beyond the United States.

Dr. Roberto Jeronimo Alvarez graduated from Higher Institute of Medical Sciences in Havana, Cuba. Dr. Jeronimo completed his board certification at the Autonomous University of Yucatán in Mexico. Dr. Jeronimo is a Pediatric Specialist in Intensive Care and Emergency Medicine.

Dr. José Miguel Lopez Zepeda

Surgeon, Obstetrician, and Homeopathic Doctor      

• Surgeon and Homeopath from the National School of Medicine and Homeopathy, National Polytechnic Medical Institute Mexico City, Mexico

• Master’s in Emotional Intelligence National Polytechnic Institute

• Master’s in NLP, Neurolinguistics Programming Mexican.

• Graduate Biomolecular Medicine. General Hospital of Mexico. 2002-2005.

• Graduate in Classical Homeopathy from The International Academy of Classical Homeopathy, Alonnisos Greece in May 2011.

• Certified by the Ortho Institute of Healing Los Angeles California in the use of Platelet Rich Plasma and Stem Cells for joint injuries.

• MBA Health Institution La Salle University.

• Diploma in Physiotherapy from UNAM

• Certified in Ozone therapy at the Institute of Neurosurgery of Havana Cuba.

• Certified Stem cells, and certification by the ORTHOBIOLOGIC INSTITUTE in Los Angeles California.

• Certified in Prolotherapy by ORTHOBIOLOGIC Institute in Los Angeles California.

• Certified by REGENESTEM in handling extraction of multipotent cells, adipose tissue, peripheral blood and bone marrow. Miami Florida USA.

• Director of Health Protection Program and life PROSALVID Mexican Red Cross, Delegation León Gto.

• Director or Education in First Aid and assistance in Mexican Red Cross Delegation León Gto.

• Advisory Council Member of the National School of Medicine and Homeopathy IPN

• He currently serves as Head of Education and Communication at the State Blood Transfusion Center of the Ministry of Health of Guanajuato

• Director of ORTHOCIMBIO Clinic and Research Center for Biomolecular Medicine based in León Gto.

• Diploma in Neural Therapy

• Diploma in Therapeutics with trace elements

• Diploma in Human Acupuncture complementary der Terapétuicas in the Mexican Association of Medical Acupuncturists, A B.C.

• Diploma in Homeopathy from the European Academy of Naturopathy ACENA, Malaga, Spain

• Diploma in Neuro Linguistic Programming. Mexican Institute of NLP.

• Diploma in Quantum Physics. Metabolic Mexican society. Dr. Sodi Pallares. Mexico DF.

• Diploma in cancer and terminal illnesses, by Dr. Hammer in Germany